BioAdaptives, Inc. (BDPT)

OTCMKTS · Delayed Price · Currency is USD

0.0150

0.00 (0.00%)

At close: Mar 5, 2026

-87.38% (1Y)

Market Cap	180.13K
Revenue (ttm)	7.85K
Net Income (ttm)	-1.11M
Shares Out	12.01M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	312,248
Average Volume	44,356
Open	0.0161
Previous Close	n/a
Day's Range	0.0133 - 0.0180
52-Week Range	0.0131 - 0.1189
Beta	1.14
RSI	42.76
Earnings Date	Mar 27, 2026

About BioAdaptives

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2013

Employees 1

Stock Exchange OTCMKTS

Ticker Symbol BDPT

Full Company Profile

Financial Performance

In 2024, BioAdaptives's revenue was $12,669, a decrease of -55.65% compared to the previous year's $28,565. Losses were -$899,161, 26.2% more than in 2023.

Financial Statements

News

There is no news available yet.